Tepotinib 225 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 225 mg
Reference Brands: Tepmetko (USA/EU)
Category: Oncology Cancer Care
Tepotinib is a Oncology Cancer Care product available as Tablets in strengths 225 mg. It corresponds to the reference brand Tepmetko (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Tepotinib is an oral anticancer medication sold under the brand name Tepmetko, used for the treatment of non-small cell lung cancer (NSCLC) in adults. It is specifically indicated for patients with metastatic NSCLC whose tumors harbor a mutation that leads to MET exon 14 skipping, a genetic alteration that drives cancer cell growth and survival.
Tepotinib works as a selective inhibitor of the MET receptor tyrosine kinase. By blocking MET signaling, it interferes with pathways that promote tumor cell proliferation, survival, and metastasis. This targeted mechanism allows for precision therapy in patients whose cancers are driven by MET exon 14 alterations. Tepotinib provides a valuable treatment option for adults with this specific form of NSCLC, offering an alternative for patients who may not respond to conventional chemotherapy.
Tepotinib — third party manufacturing & bulk supply
Tepotinib 225 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Tepotinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tepotinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Tepotinib →Frequently Asked Questions
Tepotinib is used to treat non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations by inhibiting MET receptor signaling and slowing tumor progression.
Tepotinib mesylate is a synthetic small-molecule MET kinase inhibitor that specifically targets MET-driven cancer cell growth pathways.
The trade name of tepotinib is Tepmetko.
Tepotinib (Tepmetko) is developed and marketed by Merck KGaA (EMD Serono in the USA).
The generic name is tepotinib mesylate.
The brand name is Tepmetko.
Related Products
Thiotepa
Strength:
15 mg, 100 mg
Form: Injection
Reference Brands: Thioplex (USA/EU) , Tepylute (USA)
View Details
Temsirolimus
Strength:
25 mg/ml, 100 mg
Form: Injection
Reference Brands: Torisel (USA)
View Details
Thioguanine
Strength:
20 mg, 25 mg, 40 mg
Form: Tablets
Reference Brands: Tabloid (USA), Lanvis (EU)
View Details
Deutetrabenazine
Strength:
6 mg, 9 mg, 12 mg, 15 mg, 18 mg, 21 mg, 24 mg
Form: Tablets
Reference Brands: Austedo (USA/EU)
View Details
Avapritinib
Strength:
25 mg, 100 mg, 200 mg
Form: Capsules
Reference Brands: Ayvakyt (USA/EU)
View Details
Bevacizumab
Strength:
100 mg/4 mL, 400 mg/16 mL
Form: Injection
Reference Brands: Avastin (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
